2023
DOI: 10.1177/10556656231163400
|View full text |Cite
|
Sign up to set email alerts
|

In Utero Exposure to Maternal Electronic Nicotine Delivery System use Demonstrate Alterations to Craniofacial Development

Abstract: Objective Develop a model for the study of Electronic Nicotine Device (ENDS) exposure on craniofacial development. Design Experimental preclinical design followed as pregnant murine dams were randomized and exposed to filtered air exposure, carrier exposure consisting of 50% volume of propylene glycol and vegetable glycine (ENDS Carrier) respectively, or carrier exposure with 20 mg/ml of nicotine added to the liquid vaporizer (ENDS carrier with nicotine). Setting Preclinical murine model exposure using the Sci… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 102 publications
0
1
0
Order By: Relevance
“…Our group has a keen interest in the mechanism by which established and emerging drug exposures might alter health of the mineralized tissues of the body, specifically bone. Understanding these interactions is critical as bone loss diseases are on the rise, notably osteoporosis. , The Center for Disease Control (United States) reports the age-adjusted prevalence of osteoporosis has increased in the past decade from 9.5% in 2008 to 12.6% in 2018 . Our most recent work has focused on MA and how the cells responsible for bone development, maintenance, and remodeling, osteoblasts, are affected by its exposure .…”
mentioning
confidence: 99%
“…Our group has a keen interest in the mechanism by which established and emerging drug exposures might alter health of the mineralized tissues of the body, specifically bone. Understanding these interactions is critical as bone loss diseases are on the rise, notably osteoporosis. , The Center for Disease Control (United States) reports the age-adjusted prevalence of osteoporosis has increased in the past decade from 9.5% in 2008 to 12.6% in 2018 . Our most recent work has focused on MA and how the cells responsible for bone development, maintenance, and remodeling, osteoblasts, are affected by its exposure .…”
mentioning
confidence: 99%